Arctic Bioscience AS (ABS.OL)

Name: Arctic Bioscience AS Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-04-07

Latest Quarter

2026-04-07

Revenue

$18.7M

Net Income

-$18.9M

Operating Margin

-86.5%

Free Cash Flow

-$96.2M

Debt / Assets

24.7%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Arctic Bioscience AS (ABS.OL).
Income Statement (Quarterly)	2026-04-07	2025-06-30	2025-03-31	2024-12-31
Revenue	18,695,578	18,695,578	9,347,789	27,199,830
Cost of Revenue	11,479,100	11,479,100	5,739,550	19,979,948
Gross Profit	7,216,478	7,216,478	3,608,239	7,219,882
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	10,706,074	10,706,074	5,353,037	13,005,222
Operating Expenses	23,394,018	23,394,018	11,697,009	30,825,690
Operating Income	-16,177,540	-16,177,540	-8,088,770	-23,605,808
Interest Expense	0	2,767,426	0	1,764,324
Income Before Tax	-18,944,966	-18,944,966	-9,472,483	-24,416,892
Income Tax Expense	0	0	0	0
Net Income	-18,944,966	-18,944,966	-9,472,483	-24,416,892
Per Share
EPS	-0.70	-0.70	-0.35	-0.96
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Arctic Bioscience AS (ABS.OL).
Income Statement (Annual)	2024-12-31	2023-12-31	2022-12-31
Revenue	43,484,000	33,750,017	34,271,936
Cost of Revenue	31,596,000	23,976,423	22,625,579
Gross Profit	11,888,000	9,773,594	11,646,357
Operating Expenses
R&D Expenses	0	0	0
SG&A Expenses	25,949,000	-2,583,894	0
Operating Expenses	59,677,000	58,365,487	49,035,482
Operating Income	-47,790,000	-48,586,164	-37,389,125
Interest Expense	3,148,616	992,623	1,250
Income Before Tax	-47,933,000	-45,514,667	-34,024,364
Income Tax Expense	0	0	3,366,011
Net Income	-47,933,000	-45,514,667	-34,024,364
Per Share
EPS	-1.88	-1.79	-1.40
EPS Diluted	0.00	0.00	0.00

Balance sheet quarterly history for Arctic Bioscience AS (ABS.OL).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	2,159,000	79,602,069	143,160,632
Short Term Investments	0	0	0
Net Receivables	25,622,000	9,570,595	18,712,805
Inventory	28,987,000	32,793,790	35,462,160
Total Current Assets	57,886,000	133,154,934	198,326,538
Property Plant Equipment	24,466,000	26,438,111	22,331,982
Goodwill and Intangibles	197,389,000	140,658,531	107,043,521
Total Assets	279,741,000	300,251,576	327,702,041
Liabilities
Account Payables	18,975,000	18,375,982	18,253,416
Short Term Debt	31,385,000	3,530,622	0
Total Current Liabilities	67,538,000	39,645,610	40,422,384
Long Term Debt	1,472,000	2,048,730	0
Total Liabilities	69,010,000	41,694,340	40,422,384
Shareholders Equity
Retained Earnings	0	0	0
Total Shareholders Equity	210,731,000	258,557,236	287,279,657

Balance sheet annual history for Arctic Bioscience AS (ABS.OL).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	2,159,000	79,602,069	143,160,632
Short Term Investments	0	0	0
Net Receivables	25,622,000	9,570,595	18,712,805
Inventory	28,987,000	32,793,790	35,462,160
Total Current Assets	57,886,000	133,154,934	198,326,538
Property Plant Equipment	24,466,000	26,438,111	22,331,982
Goodwill and Intangibles	197,389,000	140,658,531	107,043,521
Total Assets	279,741,000	300,251,576	327,702,041
Liabilities
Account Payables	18,975,000	18,375,982	18,253,416
Short Term Debt	31,385,000	3,530,622	0
Total Current Liabilities	67,538,000	39,645,610	40,422,384
Long Term Debt	1,472,000	2,048,730	0
Total Liabilities	69,010,000	41,694,340	40,422,384
Shareholders Equity
Retained Earnings	0	0	0
Total Shareholders Equity	210,731,000	258,557,236	287,279,657

Cash flow quarterly history for Arctic Bioscience AS (ABS.OL).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-47,933,000	-45,514,667	-34,024,364
Depreciation & Amortization	5,151,000	5,382,485	3,730,672
Stock Based Compensation	0	0	0
Change in Working Capital	-2,562,000	-154,306	4,898,372
Operating Cash Flow	-45,357,000	-40,286,488	-25,395,321
Investing Activities
Capital Expenditure	-50,813,000	-45,334,088	-58,565,456
Investments	-50,813,000	-45,334,088	-58,565,456
Investing Cash Flow	-50,629,000	-43,103,992	-58,565,456
Financing Activities
Debt Repayment	19,661,000	-2,048,730	0
Common Stock Issued/Repurchased	0	16,792,246	749,992
Dividends Paid	0	0	0
Financing Cash Flow	19,661,000	18,840,976	749,992
Summary
Free Cash Flow	-96,170,000	-85,620,576	-83,960,777
Net Change in Cash	-76,325,000	-64,549,504	-83,210,785

Cash flow annual history for Arctic Bioscience AS (ABS.OL).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-47,933,000	-45,514,667	-34,024,364
Depreciation & Amortization	5,151,000	5,382,485	3,730,672
Stock Based Compensation	0	0	0
Change in Working Capital	-2,562,000	-154,306	4,898,372
Operating Cash Flow	-45,357,000	-40,286,488	-25,395,321
Investing Activities
Capital Expenditure	-50,813,000	-45,334,088	-58,565,456
Investments	-50,813,000	-45,334,088	-58,565,456
Investing Cash Flow	-50,629,000	-43,103,992	-58,565,456
Financing Activities
Debt Repayment	19,661,000	-2,048,730	0
Common Stock Issued/Repurchased	0	16,792,246	749,992
Dividends Paid	0	0	0
Financing Cash Flow	19,661,000	18,840,976	749,992
Summary
Free Cash Flow	-96,170,000	-85,620,576	-83,960,777
Net Change in Cash	-76,325,000	-64,549,504	-83,210,785